Company: CERO
Filing Date: 2025-06-06
Form Type: 424B3
Source: 0001213900-25-052185
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-06
Form: 424B3
Chunk 3
---
 Agreement,
the satisfaction of which shall be determined by the Company’s Board of Directors (the “Board”), subject to Mr. Ehrlich’s
continued employment with the Company through the date that such bonus is paid, except that in the event of a Change of Control (as defined
in the Ehrlich Employment Agreement) Mr. Ehrlich will be entitled to receive payment of his full performance bonus. The Ehrlich Employment
Agreement also provides that Mr. Ehrlich is eligible to participate in the benefit plans of the Company, if any, in accordance with the
terms of such plans in effect from time to time, including equity awards pursuant to the Company’s 2024 Stock Option and Grant Plan,
as amended from time to time (the “Plan”). In addition, Mr. Ehrlich will be entitled to receive a monthly contribution of
up to $1,850 from the Company toward his healthcare premiums. In connection with entry into the Ehrlich Employment Agreement, Mr. Ehrlich
has received certain equity awards under the Plan, the amount of such awards, vesting schedule and performance criterial are as set forth
in the Ehrlich Employment Agreement.

The Ehrlich Employment Agreement is for no specific
period of time and either Mr. Ehrlich or the Company may terminate the employment at any time and for any reason or no reason, with or
without cause, and with or without notice.

Employment Agreement of Current CFO

On May 30, 2025, the Company entered into a new
employment agreement with Andrew Albert Kucharchuk (the “Kucharchuk Employment Agreement”), under which the Company agreed
to employ Mr. Kucharchuk as the Company’s Chief Financial Officer as of and from June 4, 2025. The agreement replaces and supersedes
that certain Consulting Agreement, dated October 1, 2024, between the Company and Mr. Kucharchuk, which was terminated in connection with
the entry into the Kucharchuk Employment Agreement. The Company determined to enter into the Kucharchuk Employment Agreement commensurate
with the expansion of the services provided by Mr. Kucharchuk to the Company to a full-time basis. Pursuant to the Kucharchuk Employment
Agreement, Mr. Kucharchuk is entitled to a base salary at a rate of $300,000 per annum effective June 4, 2025, prorated for any partial
years